Nagi Bioscience, focussing on laboratory technologies for alternative model organisms research, launched its Priority Access Program. With a focus on research applications in oncology, neurodegenerative diseases, aging and age-related conditions, and toxicology, SydLab One is set to facilitate and accelerate the ground-breaking research projects of the five participating laboratories.
Nagi is a Switzerland-based medical technology company that develops laboratory equipment and organism-on-a-chip products for sectors including biopharma and agrochemicals.